PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4700
-0.0050 (-1.05%)
Sep 3, 2026, 2:20 PM EST
PharmaCorp Rx Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1.07 | -1.48 | -1.01 | -0.47 | -0.52 | -0.08 |
Depreciation & Amortization | 1.25 | 0.94 | 0.29 | - | - | - |
Stock-Based Compensation | 0.46 | 0.41 | 0.28 | - | 0.39 | - |
Other Operating Activities | -0.07 | 0.02 | -0.14 | - | - | - |
Change in Accounts Receivable | -0.01 | -0.14 | -0 | - | - | - |
Change in Inventory | -0.36 | -0.31 | 0.11 | - | - | - |
Change in Accounts Payable | 0.01 | 2.27 | 0.5 | - | -0.01 | 0.08 |
Change in Income Taxes | 0.01 | 0.26 | 0 | - | - | - |
Change in Other Net Operating Assets | -0 | 0.05 | 0.1 | -0.05 | 0.02 | - |
Operating Cash Flow | 0.23 | 2.01 | 0.12 | -0.52 | -0.12 | 0 |
Operating Cash Flow Growth | -43.10% | 1505.50% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.19 | -0.09 | -0.01 | - | - | - |
Cash Acquisitions | -9.84 | -10.52 | -16.86 | - | - | - |
Sale (Purchase) of Intangibles | - | -2.09 | - | - | - | - |
Other Investing Activities | -1.02 | -1.02 | - | - | - | - |
Investing Cash Flow | -11.04 | -13.72 | -16.86 | - | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 3.16 | - | - | - | - |
Long-Term Debt Repaid | - | -0.32 | -0.11 | - | - | - |
Lease Payments | -0.18 | -0.14 | -0.05 | - | - | - |
Net Debt Issued (Repaid) | 2.79 | 2.84 | -0.11 | - | - | - |
Issuance of Common Stock | 21.44 | 21.44 | 27.49 | 0.03 | 2 | 3 |
Other Financing Activities | 1.03 | 0.43 | - | - | -0.13 | -0.06 |
Financing Cash Flow | 25.26 | 24.71 | 27.38 | 0.03 | 1.87 | 2.94 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 14.45 | 13 | 10.64 | -0.49 | 1.75 | 2.94 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.04 | 1.92 | 0.12 | -0.52 | -0.12 | 0 |
Free Cash Flow Growth | -87.66% | 1525.00% | - | - | - | - |
Free Cash Flow Margin | 0.16% | 9.18% | 2.04% | - | - | - |
Free Cash Flow Per Share | - | 0.01 | 0.00 | -0.03 | -0.01 | - |
Levered Free Cash Flow | -0.45 | -0.24 | -0.54 | -0.41 | 0.04 | - |
Unlevered Free Cash Flow | -0.37 | -0.2 | -0.54 | -0.41 | 0.04 | - |
Free Cash Flow After Leases | -0.14 | 1.78 | 0.07 | -0.52 | -0.12 | 0 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | -0.35 | 2.13 | 0.71 | -0.05 | 0.01 | 0.08 |